On Thursday, August 6, 2020 President Trump signed an Executive Order, mandating that certain drugs and medical supplies purchased by federal agencies, including the Department of Health and Human Services, Department of Defense, and Department of Veteran’s Affairs must be US-manufactured (the “Buy American Order” or the “Order”). The list of “essential medicines, medical countermeasures and critical input” that fall under this Order will be determined by the Food and Drug Administration (“FDA”). The Order also calls on the FDA to conduct a greater amount of unannounced inspections of overseas drug plants to ensure that production of drugs is compliant with safety standards and to encourage more advanced drug manufacturing techniques.
More Posts
The California Department of Managed Health Care Extends the Phase-In Period for the General Licensure Regulation
Supreme Court Issues Long Awaited Ruling on Affordable Care Act Risk Corridors Program
Telehealth and Online Prescribing: COVID-19 Triggers Changes to the Prescriber/Patient/Pharmacist Relationship
California Department of Managed Health Care Releases Additional Guidance on Telehealth Services
CMS Issues Temporary Waivers in Broad Coronavirus Response
Coronavirus Aid, Relief, And Economic Security Act Of 2020: Telehealth Front and Center
California Health Plans Take Note: California Department of Managed Health Care issues All Plan Letter on Social Distancing and COVID-19
ACA Medicaid Expansion Weakens: Trump Administration Unveils Optional Plan for Block Grants
The California Consumer Privacy Act of 2018: Why the Healthcare Sector Needs to Pay Attention (and Not Just in California)
Subscribe: Subscribe via RSS
Blogs